Anticancer Res

1. KIM HB, Kim SH, Lee HH, Lee HJ, et al
   POM121 Drives Gastric Cancer Progression via the mTOR/p70S6K Signaling Axis.
   Anticancer Res. 2026;46:787-795.
   

   >> Share

   
   
2. AWATSU T, Kadono T, Shoji H, Hirose T, et al
   Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab.
   Anticancer Res. 2026;46:1021-1035.
   

   >> Share

   
   
3. WADA N, Kurokawa Y, Takahashi T, Saito T, et al
   Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer.
   Anticancer Res. 2026;46:949-961.
   

   >> Share

   
   

   
   BMC Cancer

4. NAM SK, Park J, Kwak Y, Batochir C, et al
   Multi-gene DNA methylation profiles of tumor suppressor genes for prognostic prediction in gastric cancer.
   BMC Cancer. 2026 Feb 3. doi: 10.1186/s12885-026-15620.
   

   >> Share

   
   
5. CANASLAN K, Demirciler E, Celik S, Atila K, et al
   Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden.
   BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15684.
   

   >> Share

   
   
6. FANG J, Yu Y, Sun Y, Chen X, et al
   Longitudinal plasma proteome profiling identifies IFN-gamma dynamics as a time-dependent predictor of immunotherapy response in advanced gastric cancer.
   BMC Cancer. 2026 Feb 2. doi: 10.1186/s12885-026-15623.
   

   >> Share

   
   

   
   BMC Gastroenterol

7. YANAGAWA S, Yamamoto Y, Nakagawa T, Yamaguchi M, et al
   Evaluation of efficacy of a polyglycolic acid sheet in laparoscopic gastrectomy for gastric cancer: a single-center retrospective study.
   BMC Gastroenterol. 2026 Jan 30. doi: 10.1186/s12876-026-04650.
   

   >> Share

   
   

   
   BMC Surg

8. GUO R, Wu H, Han Z, Zhang L, et al
   Correction: The research progress on the application of ICG fluorescence imaging in robotic D2 lymphadenectomy for gastric cancer: a narrative review.
   BMC Surg. 2026;26:97.
   

   >> Share

   
   

   
   Clin Cancer Res

9. SUN Z, Li Z, Ahmad MU, Zhu Y, et al
   Non-invasive Imaging Assessment of Tertiary Lymphoid Structures and Immunotherapy Response in Gastric Cancer: A Multicenter Study.
   Clin Cancer Res. 2026 Feb 5. doi: 10.1158/1078-0432.CCR-25-3669.
   

   >> Share

   
   

   
   Eur J Surg Oncol

10. ERNUDD I, Mattsson F, Leijonmarck W, Sonden A, et al
    In-hospital complications after gastrectomy in relation to long-term survival in gastric adenocarcinoma: a population-based cohort study.
    Eur J Surg Oncol. 2026;52:111367.
    

    >> Share

    
    
11. ZHANG F, Yan Y, Li B, Wang Y, et al
    Comparative short-term outcomes of peri-operative immunotherapy and targeted therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis.
    Eur J Surg Oncol. 2026;52:111311.
    

    >> Share

    
    

    
    Gut

12. CHANG YH, Hong TC, Lin KT, Hsiao YJ, et al
    Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer.
    Gut. 2026 Jan 30:gutjnl-2025-337247. doi: 10.1136/gutjnl-2025-337247.
    

    >> Share

    
    

    
    Hum Pathol

13. AZIMPOURAN M, Waters KM, Hendifar AE, Gangi A, et al
    Gastric neuroendocrine tumors associated with acid suppressant drugs are frequently associated with very prolonged drug use and may show unconventional morphologies.
    Hum Pathol. 2026;168:106013.
    

    >> Share

    
    

    
    Minerva Surg

14. LESSING Y, Inbar-Weissman T, Cohen R, Messer N, et al
    Comparing palliative gastrectomy and gastrojejunostomy for advanced gastric cancer: impact on survival and postoperative outcomes.
    Minerva Surg. 2025;80:452-460.
    

    >> Share

    
    

    
    Mol Ther Oncol

15. OKURA T, Kikuchi S, Tazawa H, Mikane Y, et al
    Collagen depletion by pirfenidone enhances antitumor effect of oncolytic adenovirus against peritoneal metastases of gastric cancer.
    Mol Ther Oncol. 2025;33:201045.
    

    >> Share

    
    

    
    Oncology

16. WU S, Niu J, Ding C, Ke L, et al
    Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial.
    Oncology. 2026;104:201-211.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share